India's 2026 transgender law disrupts care
Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026
The law creates regulatory uncertainty for healthcare providers in India, potentially reducing demand for gender-affirming treatments and impacting related pharmaceutical sales. However, the direct market impact is limited as the affected population is a small segment.
In March 2026, India enacted a law that scrapped self-identification for transgender people, requiring certification by a panel of doctors for legal gender recognition. The government has not specified the panel's composition, causing confusion among healthcare providers. Many clinics have paused gender-affirming care, including hormone therapy and surgeries, affecting thousands. Activists and doctors warn of a public health emergency, with risks of unregulated care. The law also explicitly bars self-identification and recognizes only traditional groups, intersex people, and those 'coerced' into being transgender. This reverses a 2014 Supreme Court ruling recognizing a third gender. The change is part of a global trend, with the US also limiting access to such care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard